CURX (STOCKS)
Curanex Pharmaceuticals Inc Common Stock
$0.454600
-0.009500 (-2.05%)
Prev close: $0.464100
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- CEO
- Jun Liu
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $13.95M
- Employees
- —
- P/E (TTM)
- -3.20
- P/B (TTM)
- 1.17
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $4.24M |
| Operating Income/Loss | -$4.24M |
| Income/Loss From Continuing Operations After Tax | -$4.23M |
| Income/Loss From Continuing Operations Before Tax | -$4.23M |
| Net Income/Loss | -$4.23M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$4.23M |
| Net Income/Loss Available To Common Stockholders, Basic | -$4.23M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.17 |
| Diluted Earnings Per Share | -$0.17 |
| Basic Average Shares | 25,497,328 |
| Diluted Average Shares | 25,497,328 |
| Assets | $11.58M |
| Current Assets | $11.23M |
| Prepaid Expenses | $6.25M |
| Other Current Assets | $4.97M |
| Noncurrent Assets | $352.62K |
| Liabilities | $361.04K |
| Current Liabilities | $137.03K |
| Accounts Payable | $2.43K |
| Other Current Liabilities | $134.60K |
| Noncurrent Liabilities | $224.01K |
| Equity | $11.22M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $11.22M |
| Liabilities And Equity | $11.58M |
| Net Cash Flow From Operating Activities | -$10.48M |
| Net Cash Flow From Operating Activities, Continuing | -$10.48M |
| Net Cash Flow From Investing Activities | -$4.82M |
| Net Cash Flow From Investing Activities, Continuing | -$4.82M |
| Net Cash Flow From Financing Activities | $15.31M |
| Net Cash Flow From Financing Activities, Continuing | $15.31M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$4.23M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$4.23M |
| Other Comprehensive Income/Loss | $0.00 |